Recursion Overview

  • Founded
  • 2013
Founded
  • Status
  • Public
  • Employees
  • 214
Employees
  • Stock Symbol
  • RXRX
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $22.66
  • (As of Tuesday Closing)

Recursion General Information

Description

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 41 South Rio Grande Street
  • Salt Lake City, UT 84101
  • United States
+1 (385) 000-0000

Recursion Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Recursion Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$22.66 $23.04 $21.06 - $35.78 $3.76B 166M 851K -$0.77

Recursion Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
Revenue 3,962 3,962 2,319
EBITDA (81,540) (81,540) (59,442)
Net Income (87,006) (87,006) (61,879)
Total Assets 298,585 298,585 101,431
Total Debt 15,662 15,662 16,169
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Recursion Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Recursion‘s full profile, request access.

Request a free trial

Recursion Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Recursion‘s full profile, request access.

Request a free trial

Recursion Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technolog
Drug Discovery
Salt Lake City, UT
214 As of 2021
00000
0.000 0000-00-00
00000000 00000

0000000

u fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia d
0000000000000
Branford, CT

00 00000

velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident,
0000 000000000
Guilford, CT
00 As of 0000
0000
000000000 - 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Recursion Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioXcel Corporation Branford, CT
00 000000000000 Venture Capital-Backed Guilford, CT 00 0000 000000000 - 0000
0000000 Venture Capital-Backed Toronto, Canada 00 000.00 00000 000.00
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
0000 0000000000000 Venture Capital-Backed Palo Alto, CA 00 000.00 000000000 - 000.00
You’re viewing 5 of 25 competitors. Get the full list »

Recursion Executive Team (23)

Name Title Board Seat Contact Info
Christopher Gibson Ph.D Chief Executive Officer & Founder
Tina Larson Chief Operating Officer, Operations & President
Ben Mabey Chief Technology Officer
Louisa Daniels JD General Counsel, Legal & Chief Legal Officer, Legal
Sharath Hegde Chief Scientific Officer
You’re viewing 5 of 23 executive team members. Get the full list »

Recursion Board Members (14)

Name Representing Role Since
Alaa Halawa Mubadala Investment Company Board Observer 000 0000
Blake Borgeson Ph.D Recursion Founder & Board Member 000 0000
Dean Li Ph.D Recursion Co-Founder & Board Member 000 0000
James Hardiman Data Collective Board Observer 000 0000
Lee Cooper JD Self Board Observer 000 0000
You’re viewing 5 of 14 board members. Get the full list »

Recursion Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Recursion Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Recursion‘s full profile, request access.

Request a free trial

Recursion Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 28-Jul-2020 000000000000000000 Discovery Tools (Healthcare) 00000000000 000000 00.0
To view Recursion’s complete acquisitions history, request access »

Recursion Subsidiaries (1)

Company Name Industry Location Founded
0000 Discovery Tools (Healthcare) San Mateo, CA 0000
To view Recursion’s complete subsidiaries history, request access »